Desert Daily

Humanized Mouse Model Market Share To Reach USD 238.7 Million By 2028 | Top Key Players The Jackson Laboratory, Taconic Biosciences, Inc., Horizon Discovery Group Plc

 Breaking News
  • No posts were found

Humanized Mouse Model Market Share To Reach USD 238.7 Million By 2028 | Top Key Players The Jackson Laboratory, Taconic Biosciences, Inc., Horizon Discovery Group Plc

August 26
16:00 2021
Humanized Mouse Model Market Share To Reach USD 238.7 Million By 2028 | Top Key Players The Jackson Laboratory, Taconic Biosciences, Inc., Horizon Discovery Group Plc
Rapid growth of biopharmaceutical sector, growing demand for personalized medicine, and increasing research activities using humanized mice models are key factors driving revenue market growth

The global humanized mouse model market size is expected to reach USD 238.7 Million by 2028 at a CAGR of 10.2%, according to the latest report by Reports and Data. Increasing us of humanized mouse models in cancer research, advancements in biopharmaceutical sector, rapid progress in drug research and development, and technological advancements in R&D sector are key factors expected to drive market revenue growth over the forecast period. In addition, growing private and public funding and increasing demand for personalized medicine are expected to further contribute to market growth going ahead.

Humanized mouse models are mice that have been xenotransplanted with human cells or are genetically engineered to express human genes. These mice are extensively used in elucidating and understanding human physiology and etiology of human-specific infections. Humanized mice are used in biomedical research to develop human therapeutics owing to their numerous benefits such as small size, short reproductive cycle, easy-to-handle, and increased genomic similarity to humans. These humanized mice are critical tools in preclinical research studies as they can mimic several human-specific diseases and can be used to study the efficacy and safety of immunotherapy approaches. Humanized mouse models have also played a major role in design and development of vaccines and antibody-based therapies for COVID-19 illness. Humanized mouse models developed since the outbreak of coronavirus infection are expected to provide deeper and better understanding of the infection, efficacy of anti-viral therapeutics, and support the development of efficient drugs and therapies for treatment of this diseases. This is expected to continue to be prevalent going ahead and contribute to revenue growth of the market.

Humanized mouse models are extensively used in the research and development activities for oncology, infectious diseases, transplantation, regenerative medicine, and toxicology studies. The advent of highly advanced gene editing tools to engineer mouse genomes is also expected to contribute to market growth going ahead. However, stringent laws and regulations regarding use of animals in experiments and increasing preference for humanized rat models is expected to hamper market growth to a certain extent over the forecast period.

 Get a sample of the report @

The global Humanized Mouse Model market is expected to register significant growth throughout the forecast period. The pharmaceutical & healthcare sector has register significant revenue growth over the recent past. Technological advancements in the healthcare and medical sector, availability of latest tools and techniques, increasing investments in the healthcare sector and improving healthcare infrastructure are key factors boosting market growth. In addition, rising funds by several public and private sectors, high adoption of POC diagnosis and home care settings, is further fueling market growth.

The current pandemic has been very challenging for all industries including the healthcare and pharma sector. Shortage of medicines, vaccines and others healthcare facilities is expected to open lucrative growth opportunities for market players in going ahead.

Competitive Landscape:

The report offers detailed information about recent activities by market players, their market position, financial status, global standing, services and product portfolio along with license agreement. These key players are adopting various strategies such as partnerships, collaborations, merger and acquisitions, and joint ventures to gain robust footing in the market. These players are also investing in research and development activities to come up with enhanced materials and products.

Some Key Highlights From the Report:

  • Genetic type segment is expected to account for largest revenue share in the global market over the forecast period owing to increasing use of genetic humanized mice models in experimental assessment of compounds to test their safety and efficacy and to study drug metabolism in drug discovery and development studies.
  • Oncology segment is expected to register rapid revenue CAGR over the forecast period attributable to increasing incidence of cancer globally, advancement in cancer research, and growing need to meet the unmet clinical demands of cancer treatment.
  • Contract Research Organizations (CROs) segment revenue is expected to expand significantly over the forecast period due to increasing outsourcing activities by pharmaceutical and biotechnology companies, rising network of CROs across the globe, and technological advancement.
  • North America is expected to register considerable revenue growth over the forecast period attributable to rising biomedical research, increasing demand and production of monoclonal antibodies, increasing preclinical studies by CROs, and advancements in stem cell and protein therapeutic research.
  • Major companies operating in the market include The Jackson Laboratory, Taconic Biosciences, Inc., Horizon Discovery Group Plc, genOway, S.A., Charles River Laboratories, Harbour Antibodies BV, Hera BioLabs, Vitalstar Biotechnology Co., Ltd., inGenious Targeting Laboratory, AXENIS S.A.S, Crown Bioscience, Inc., Transgenic, Inc., and Champions Oncology, Inc., among others.
  • In February 2020, Taconic Biosciences, which is a renowned provider of drug discovery animal model solutions, announced expansion of its humanized mouse model production by commencing production in Europe. The local production is expected to help European researchers gain easy and timely access to humanized mouse models for immune-oncology research.

Request a discount on the report @

For the purpose of this report, Reports and Data has segmented the global humanized mouse model market based on type, application, end-use, and region:   

Type Outlook (Revenue, USD Million; 2018-2028)

  • Genetic
  • Cell-based
    • CD34 Humanized Mouse Models
    • PBMC Humanized Mouse Models
    • BLT Humanized Mouse Models

Application Outlook (Revenue, USD Million; 2018-2028)

  • Oncology
  • Immunology
  • Infectious Diseases
  • Neuroscience
  • Toxicology
  • Hematopoiesis
  • Other Applications

End-use Outlook (Revenue, USD Million; 2018-2028)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutions

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request a customization of the report @

Key findings in the report:

  • Information about key trends, technological developments, growing focus on drug discovery  and investments in research and development activities
  • Detailed insights about manufactures, product portfolios, pricing analysis and financial pricing
  • Technological developments and detailed analysis in the volatile competitive landscape.
  • New strategies adopted by new and emerging market players
  • Estimation about manufactures, sales and import and export dynamics

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States